China Pharma Holdings (CPHI) Income from Non-Controlling Interests (2012 - 2015)
China Pharma Holdings' (CPHI) quarterly Income from Non-Controlling Interests came in at $1.4 million in Q2 2015, up 116.33% on a YoY basis from $640928.2 in Q2 2014, and up 116.33% quarter-over-quarter from -$8.5 million in Q2 2014.
Powered by 
Analysis
China Pharma Holdings (CPHI) Income from Non-Controlling Interests (2012 - 2015) Analysis & Trends
China Pharma Holdings (CPHI) has reported Income from Non-Controlling Interests for 4 consecutive years, with $1.4 million the latest figure, recorded in Q2 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 3.00 Mn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -2.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -7.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 10.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 39.52 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2015 | 1.39 Mn |
| Jun 30, 2014 | -8.49 Mn |
| Sep 30, 2013 | -1.42 Mn |
| Sep 30, 2012 | 1.17 Mn |